An unmet medical need vs. regulatory recommendations: how should we treat patients with hyperaldosteronism and advanced chronic kidney disease when surgery is not feasible?

Autor:	Ivana Mikačić
Rok vydání:	2019
Předmět:	Pharmacology medicine.medical_specialty business.industry Pharmacology toxicology General Medicine medicine.disease Hyperaldosteronism Eplerenone chemistry.chemical_compound chemistry Spironolactone Medicine Pharmacology (medical) business Intensive care medicine medicine.drug Kidney disease
Zdroj:	European Journal of Clinical Pharmacology. 76:131-132
ISSN:	1432-1041 0031-6970
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::27ebeb2b21dea28b85b56caec1f38c1f https://doi.org/10.1007/s00228-019-02774-2 Zobrazit plný text záznamu Full text from SpringerLink